Assessment | ||||
---|---|---|---|---|
 | RECIST 1.1 | Hystopathology pCR | Hystopathology non-pCR (pPR, pSD, pPD) |  |
CESM | CR | 8 | 6 | PPV 57% (CI 29–82%) |
non-CR (PR, SD, PD) | 0 | 32 | NPV 100% (CI 90–100%) | |
 | Sensitivity 100% (CI 63–100%) | Specificity 84% (CI 69–94%) |  | |
MRI | CR | 7 | 15 | PPV 32% (CI 14–55%) |
non-CR (PR, SD, PD) | 1 | 23 | NPV 96% (CI 79–100%) | |
 | Sensitivity 87% (CI 47–100%) | Specificity 60% (CI 43–76%) |  |